From Idea to Library: The Process to Deliver 40,000 Unique Lead-like Compounds


The ELF is a €200M project (supported by the Innovative Medicines Initiative and European Federation of Pharmaceutical Industries and Associations (EFPIA)) that aims to promote drug discovery in Europe by producing a new collection of 500,000 drug-like compounds for high throughput screening (HTS) by the public sector in a variety of therapeutic areas.

  • 300,000 compounds have been donated by EFPIA partners.
  • 200,000 compounds are being designed, generated and synthesised equally by Sygnature Discovery and four other SMEs in collaboration with academia.
  • The new libraries being synthesised will focus on: novelty, shape (eg. sp3-rich cores), diversity potential and innovative library design and will complement classical compound collections.

Download Poster

Poster download form with organisation field
Invalid email address provided.
Please only use your business email address.